BackCellular Biomedicine Group Overview

Cellular Biomedicine Group Current Assets

Latest current assets for CBMG: $28M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$27.87M
↓ 42.20% YoYΔ $-20.35M vs prior year quarter

Peer trimmed avg / median

Loading

Cellular Biomedicine Group Current Assets History

Loading

Cellular Biomedicine Group vs. peers: Current Assets Comparison

Loading

Cellular Biomedicine Group Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cellular Biomedicine Group (CBMG) FAQ

As of the most recent data (September 2020), CBMG shows a current assets of $28M. That compares with $48M in the prior-year period — down 42.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CBMG's current assets is now $28M (was $48M) — a 42.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cellular Biomedicine Group is outperforming or lagging.

Tracking CBMG's current assets over time shows whether Cellular Biomedicine Group is scaling, shrinking, or reshaping that part of the business. The current reading is $28M That compares with $48M in the prior-year period — down 42.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Cellular Biomedicine Group's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $28M) with ownership activity and broader fundamentals.

Cellular Biomedicine Group's current assets is $28M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.